LIMSA FC has patented the next generation of local hemostatic agents for use in surgery and wound healing. The Technology developed by LIMSA is safe, highly effective, affordable and will have large availability
LIMSA FC is developing the first non absorbable compound to control bladder hematuria and provide better quality of leaving to cancer patients undergoing radiation
LIMSA FC develops technology that will allow Ophthalmologists to paractice safe and effective procedures to revert retonopathy and avoid Diabetic Blindness
LIMSA FC developes bacteriostatic drugs with the potential to susbtitute antibiotics in the treatment of ear, throat and nose infections.
Need Help? Chat with us
Start a Conversation
Hi! Click one of our member below to chat on Whatsapp
